BETOPTIC S Drug Patent Profile

✉ Email this page to a colleague

When do Betoptic S patents expire, and what generic alternatives are available?

Betoptic S is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in BETOPTIC S is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Betoptic S

A generic version of BETOPTIC S was approved as betaxolol hydrochloride by EPIC PHARMA on October 22^nd, 1999.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for BETOPTIC S?
What are the global sales for BETOPTIC S?
What is Average Wholesale Price for BETOPTIC S?

Summary for BETOPTIC S

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	137
Clinical Trials:	1
Patent Applications:	1,685
Drug Prices:	Drug price information for BETOPTIC S
What excipients (inactive ingredients) are in BETOPTIC S?	BETOPTIC S excipients list
DailyMed Link:	BETOPTIC S at DailyMed

Drug patent expirations by year for BETOPTIC S

Recent Clinical Trials for BETOPTIC S

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Alcon Research	Phase 3

See all BETOPTIC S clinical trials

Pharmacology for BETOPTIC S

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

US Patents and Regulatory Information for BETOPTIC S

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	BETOPTIC S	betaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	019845-001	Dec 29, 1989		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for BETOPTIC S

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	BETOPTIC S	betaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	019845-001	Dec 29, 1989	⤷ Sign Up	⤷ Sign Up
Novartis	BETOPTIC S	betaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	019845-001	Dec 29, 1989	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for BETOPTIC S

See the table below for patents covering BETOPTIC S around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0741563		⤷ Sign Up
Finland	962976		⤷ Sign Up
Canada	2181929	COMPOSITIONS DE TRAITEMENT DU GLAUCOME COMPRENANT DE LA PILOCARPINE ET UN BETA-BLOQUANT (COMPOSITIONS FOR TREATMENT OF GLAUCOMA COMPRISING PILOCARPINE AND A BETA-BLOCKER)	⤷ Sign Up
Japan	2854418		⤷ Sign Up
Australia	1607495		⤷ Sign Up
Mexico	9203521	FORMULACION DE ALIVIO, DE LIBERACION SUSTENTADA PARA TERAPIA DE GLAUCOMA.	⤷ Sign Up
Hong Kong	135695	Sustained-release compositions containing cation exchange resins and polycarboxylic polymers	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for BETOPTIC S

Recent Clinical Trials for BETOPTIC S

Pharmacology for BETOPTIC S

Make Better Decisions: Try a trial or see plans & pricing